4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0001209191-22-020683
Chief Medical Officer bought 14,604 shares at $2.16 ($31,545)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lindmark Bertil Chief Medical Officer | 2022-03-22 | Purchase | +14,604 | $2.16 | $31,545 | 16,604 | D |
| Open-market purchases · 14,604 sh · avg $2.16 · $31,545 | |||||||
Loading xslF345X03/doc4.xml…